AACR Virtual Meeting II Poster Session
EMD Serono’s Dr. O’Rourke, et. al. presents comparison of
HTG EdgeSeq technology
- Category:
- Past Events
News & Events
ASCO 2020 Virtual Scientific Meeting Poster Session
Platform comparison of HTG EdgeSeq and RNA-Seq for gene expression profiling of tumor tissue specimens.
- Category:
- Past Events
LinkedIn Webinar: Virtual Podium 2020, Session 6, Precision Medicine
Listen to HTG’s presentation on New End-User Bioinformatics Pipeline for Patient Stratification in Precision Medicine.
- Category:
- Past Events
HTG Molecular Diagnostics Reports First Quarter 2020 Results
Call scheduled for today, May 13, at 4:30pm ET TUCSON, Ariz. , May 13, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the first quarter ended March 31,…
- Category:
- Press Releases
HTG Molecular Diagnostics to Announce First Quarter 2020 Financial Results and Host Conference Call on Wednesday, May 13
TUCSON, Ariz. , May 11, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the first quarter ended March 31, 2020 after the market close on…
- Category:
- Press Releases
LinkedIn Webinar: New end-user bioinformatics pipeline for patient stratification in precision medicine
Virtual Podium presentation by Dr. James Cooley. Register now!
- Category:
- Past Events
HTG Molecular Diagnostics Reports Full Year 2019 Results
Increased product and product-related services revenue over prior year, benefitting from expanded menu of profiling assays and increased number of customers adopting technology Released new HTG EdgeSeq Reveal data analysis software (version 2.0.0) Call scheduled for today, March 25 , at 4:30pm ET…
- Category:
- Press Releases
HTG Molecular Diagnostics to Announce Year End 2019 Financial Results and Host Conference Call on Wednesday, March 25
TUCSON, Ariz. , March 17, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will report its financial results for the year ended December 31, 2019 after the market close on Wednesday…
- Category:
- Press Releases
USCAP 2020 Customer Presentation by Dr. Leonie AS Frauenfeld
Presentation Background: Diffuse large B-cell lymphoma (DLBCL) is the most common NHL in adults. Gene expression profiling (GEP) divides DLBCL according to the cell of origin (COO) into three subgroups: GCB, ABC and unclassifiable (UNC), exhibiting different mutational profiles.
- Category:
- Past Events
USCAP 2020 Customer Poster by Dr. Michael J. Hwang
Sarcomatoid Renal Cell Carcinoma Demonstrates an Immunosuppressive Tumor Microenvironment – Implication for Therapeutic Benefit in the Immunotherapy Era
Renal cell carcinoma (RCC) with sarcomatoid features (sRCC) is an aggressive form of RCC with poor response to conventional therapies. Immune checkpoint inhibitors have shown promising therapeutic effect for sRCC in recent small series and sRCC has demonstrated higher PD-L1 expression and PD-1 positive tumor-infiltrating lymphocytes compared to high-grade clear cell RCC (ccRCC). Our aim was to use multiplexed gene expression assays to gain a broader view of the underlying tumor microenvironment in sRCC.
- Category:
- Past Events
HTG Molecular to Present Corporate Overview at the SVB Leerink 9th Annual Global Healthcare Conference
TUCSON, Ariz. , Feb. 19, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that John Lubniewski , President and CEO, will present a corporate overview at the SVB Leerink 9 th Annual…
- Category:
- Press Releases
Page last updated March 20, 2023